Acme is a leading provider of Oral Solid and Sterile Dosage form Contract Manufacturing andDevelopment services to the pharmaceutical industry.Acme began its journey in 2005 and in a decade has transformed into a trusted partner and acomplete solution provider, having expanded into niche segments of Oral Hormones bothSex Hormones and Levothyroxine along with General Injectables both Liquids andLyophilized, catering through three state of the art manufacturing facilities.Today it employs more than 1500 highly- skilled workforce in its facilitieswhich are located in Northern India, the facilities are spread over anarea of approx 500,000 sq ft having a capacity of 15 Billion Tablets, 5Billion Capsules and 42 Million Ampoules / Vials.In our journey over the past decade we have been audited andapproved by various international regulatory agencies like UKMHRA,EU-GMP- Hungary, ANVISA, PICS-Ukraine, INVIMA,WHO-Geneva, Phillippines, Vietnam, TFDA, Nepal, NAFDACNigeria,Niger, NDA Uganda, FDA Ghana, PPB Kenya, DDA Nepal, DDFCambodia, Senegal, Sierra Leone, US FDA filing planned for Q1, 2018 andUL for 21CFR Parts 210 & 211 as we continue our journey towards building asustainable future we have audits lined by US FDA* in 2018